Topical Vitamin C for Treatment of Basal Cell Cancer

Completed · Early Phase 1

Conditions studied: Basal Cell Carcinoma

In brief

Randomized coomparative trial of a 30% solution of ascorbic acid in 95% dimethylsulfoxide applied topically twice a day for 8 weeks vs 5% imiquimod cream in the treatment biopsy proven basal cell carcinomas inotherwise healthy adult patients. Outcome measure was biopsy proven resolution of the carcinoma.

Key facts

Study ID
NCT04279535
Run by
Center for Biomedical Research, Inc.
People needed
25
Starts
2018-03-01
Expected to finish
2019-06-01
Last updated by the study team
2021-11-02

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.